Cargando…
Antibacterial Peptide Nucleic Acids—Facts and Perspectives
Antibiotic resistance is an escalating, worldwide problem. Due to excessive use of antibiotics, multidrug-resistant bacteria have become a serious threat and a major global healthcare problem of the 21st century. This fact creates an urgent need for new and effective antimicrobials. The common strat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038079/ https://www.ncbi.nlm.nih.gov/pubmed/32012929 http://dx.doi.org/10.3390/molecules25030559 |
_version_ | 1783500571601272832 |
---|---|
author | Wojciechowska, Monika Równicki, Marcin Mieczkowski, Adam Miszkiewicz, Joanna Trylska, Joanna |
author_facet | Wojciechowska, Monika Równicki, Marcin Mieczkowski, Adam Miszkiewicz, Joanna Trylska, Joanna |
author_sort | Wojciechowska, Monika |
collection | PubMed |
description | Antibiotic resistance is an escalating, worldwide problem. Due to excessive use of antibiotics, multidrug-resistant bacteria have become a serious threat and a major global healthcare problem of the 21st century. This fact creates an urgent need for new and effective antimicrobials. The common strategies for antibiotic discovery are based on either modifying existing antibiotics or screening compound libraries, but these strategies have not been successful in recent decades. An alternative approach could be to use gene-specific oligonucleotides, such as peptide nucleic acid (PNA) oligomers, that can specifically target any single pathogen. This approach broadens the range of potential targets to any gene with a known sequence in any bacterium, and could significantly reduce the time required to discover new antimicrobials or their redesign, if resistance arises. We review the potential of PNA as an antibacterial molecule. First, we describe the physicochemical properties of PNA and modifications of the PNA backbone and nucleobases. Second, we review the carriers used to transport PNA to bacterial cells. Furthermore, we discuss the PNA targets in antibacterial studies focusing on antisense PNA targeting bacterial mRNA and rRNA. |
format | Online Article Text |
id | pubmed-7038079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70380792020-03-10 Antibacterial Peptide Nucleic Acids—Facts and Perspectives Wojciechowska, Monika Równicki, Marcin Mieczkowski, Adam Miszkiewicz, Joanna Trylska, Joanna Molecules Review Antibiotic resistance is an escalating, worldwide problem. Due to excessive use of antibiotics, multidrug-resistant bacteria have become a serious threat and a major global healthcare problem of the 21st century. This fact creates an urgent need for new and effective antimicrobials. The common strategies for antibiotic discovery are based on either modifying existing antibiotics or screening compound libraries, but these strategies have not been successful in recent decades. An alternative approach could be to use gene-specific oligonucleotides, such as peptide nucleic acid (PNA) oligomers, that can specifically target any single pathogen. This approach broadens the range of potential targets to any gene with a known sequence in any bacterium, and could significantly reduce the time required to discover new antimicrobials or their redesign, if resistance arises. We review the potential of PNA as an antibacterial molecule. First, we describe the physicochemical properties of PNA and modifications of the PNA backbone and nucleobases. Second, we review the carriers used to transport PNA to bacterial cells. Furthermore, we discuss the PNA targets in antibacterial studies focusing on antisense PNA targeting bacterial mRNA and rRNA. MDPI 2020-01-28 /pmc/articles/PMC7038079/ /pubmed/32012929 http://dx.doi.org/10.3390/molecules25030559 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Wojciechowska, Monika Równicki, Marcin Mieczkowski, Adam Miszkiewicz, Joanna Trylska, Joanna Antibacterial Peptide Nucleic Acids—Facts and Perspectives |
title | Antibacterial Peptide Nucleic Acids—Facts and Perspectives |
title_full | Antibacterial Peptide Nucleic Acids—Facts and Perspectives |
title_fullStr | Antibacterial Peptide Nucleic Acids—Facts and Perspectives |
title_full_unstemmed | Antibacterial Peptide Nucleic Acids—Facts and Perspectives |
title_short | Antibacterial Peptide Nucleic Acids—Facts and Perspectives |
title_sort | antibacterial peptide nucleic acids—facts and perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038079/ https://www.ncbi.nlm.nih.gov/pubmed/32012929 http://dx.doi.org/10.3390/molecules25030559 |
work_keys_str_mv | AT wojciechowskamonika antibacterialpeptidenucleicacidsfactsandperspectives AT rownickimarcin antibacterialpeptidenucleicacidsfactsandperspectives AT mieczkowskiadam antibacterialpeptidenucleicacidsfactsandperspectives AT miszkiewiczjoanna antibacterialpeptidenucleicacidsfactsandperspectives AT trylskajoanna antibacterialpeptidenucleicacidsfactsandperspectives |